The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q1 2023 call → NOThe question asks whether management conveys that the reported results do not represent the business as it is actually running today — that the reported period is stale relative to the operating present. Looking at the transcript, management discusses several key developments: - SP2 electrolyte production facility began production in April (after Q1 ended) - 20-amp hour cell yields have increased - EV cell development on track - New revenue from BMW agreement in Q1 - The company is transitioning from SP1 to SP2 for powder production The key question: does management convey that the reported Q1 results don't represent the current business? The Q1 results show revenue of $3.8 million, operating loss of $21.3 million. Management discusses that SP2 production began in April (after Q1), that they're transitioning production from SP1 to SP2, that yields have improved, and that they're on track for EV cells by year-end. However, the call is largely a standard results-and-outlook discussion. Management discusses progress, milestones, and forward plans. The SP2 facility coming online in April is a significant milestone, but the company is still in development stage — it's not as if the reported period shows a business that has been left behind by what's now happening. The company is pre-revenue in terms of commercial products, still in development. The SP2 startup is a milestone but the company is still testing powder, still developing cells, still years from commercialization. The reported period and the described business are essentially the same size — a development-stage company making progress. Management does note that SP2 production began in April, which is after Q1, but this is a routine development milestone for a company in this stage. The company isn't saying "the numbers don't reflect what we're actually doing now" in a way that suggests the business has moved to a different level. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.